Please Wait
Applying Filters...
menu
    • menu
    Cayman Pharma s.r.o-PSE
    News
    CABRI Opens College Research Fellow Training Program Today

    11 Sep 2024

    // PRESS RELEASE

    Cayman Certest Join To Boost Lipid Access For Nano Tech Use

    21 Aug 2024

    // PRESS RELEASE

    Cayman Chemical Enhances Molecular Diagnostic Research Via PCRassays.com Deal

    05 Jun 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Cayman 250

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
    Menu

    Cayman Chemical Company Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1LATANOPROST DRUG SUBSTANCE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Contact Cayman Chemical Company Inc and get a quotation

    Cayman Chemical Company Inc is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Latanoprost bulk with DMF, CEP, JDMF offered by Cayman Chemical Company Inc